Morgan Stanley 13D and 13G filings for Royalty Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 3:15 pm Sale |
2024-09-30 | 13G | Royalty Pharma plc RPRX |
MORGAN STANLEY MS |
36,517,159 8.200% |
-4,642,590 (-11.28%) |
Filing |
| 2024-02-09 3:13 pm Sale |
2023-12-31 | 13G | Royalty Pharma plc RPRX |
MORGAN STANLEY MS |
41,159,749 9.200% |
-2,615,649 (-5.98%) |
Filing |
| 2023-02-10 3:21 pm Sale |
2022-12-30 | 13G | Royalty Pharma plc RPRX |
MORGAN STANLEY MS |
43,775,398 9.900% |
-12,235,612 (-21.85%) |
Filing |
| 2022-02-10 4:43 pm Purchase |
2021-12-31 | 13G | Royalty Pharma plc RPRX |
MORGAN STANLEY MS |
56,011,010 13.000% |
9,866,127 (+21.38%) |
Filing |
| 2021-02-10 4:05 pm Purchase |
2021-01-29 | 13G | Royalty Pharma plc RPRX |
MORGAN STANLEY MS |
46,144,883 11.900% |
22,547,596 (+95.55%) |
Filing |
| 2021-02-09 4:53 pm Purchase |
2020-12-31 | 13G | Royalty Pharma plc RPRX |
MORGAN STANLEY MS |
23,597,287 6.100% |
23,597,287 (New Position) |
Filing |